CTMX CytomX Therapeutics, Inc.
Healthcare$3.76+0.00%ClosedMarket Cap: $604.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$10.71
Target (Median)
$10.00
Target Range
$6.00 - $16.00
Upside from current price: 184.8%
Rating Distribution
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-23 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-19 | Barclays | maintain | Overweight | Overweight |
| 2026-03-18 | Jefferies | maintain | Buy | Buy |
| 2026-03-18 | Guggenheim | maintain | Buy | Buy |
| 2026-03-17 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-16 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-16 | JP Morgan | upgrade | Overweight | Neutral |
| 2026-02-04 | Barclays | maintain | Overweight | Overweight |
| 2026-02-04 | Cantor Fitzgerald | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.52 | $29.4M | 7 |
| Sun Dec 31 | $-0.49 | $38.9M | 5 |
| Mon Dec 31 | $-0.59 | $56.1M | 1 |
| Tue Dec 31 | $-0.11 | $204.2M | 1 |